Abstract:Approximately half of patients with cancer receive radiotherapy and, as cancer survivorship increases, the low rate of radiation-associated sarcomas is rising. Pharmacologic inhibition of p53 has been proposed as an approach to ameliorate acute injury of normal tissues from genotoxic therapies, but how this might impact the risk of therapy-induced cancer and normal tissue injuries remains unclear. We utilized mice that express a doxycycline (dox)-inducible p53 short hairpin RNA to reduce Trp53 expression temporarily during irradiation. Mice were placed on a dox diet 10 days prior to receiving 30 or 40 Gy hind limb irradiation in a single fraction and then returned to normal chow. Mice were examined weekly for sarcoma development and scored for radiation-induced normal tissue injuries. Radiation-induced sarcomas were subjected to RNA sequencing. Following single high-dose irradiation, 21% of animals with temporary p53 knockdown during irradiation developed a sarcoma in the radiation field compared with 2% of control animals. Following high-dose irradiation, p53 knockdown preserves muscle stem cells, and increases sarcoma development. Mice with severe acute radiation-induced injuries exhibit an increased risk of developing late persistent wounds, which were associated with sarcomagenesis. RNA sequencing revealed radiation-induced sarcomas upregulate genes related to translation, epithelial-mesenchymal transition (EMT), inflammation, and the cell cycle. Comparison of the transcriptomes of human and mouse sarcomas that arose in irradiated tissues revealed regulation of common gene programs, including elevated EMT pathway gene expression. These results suggest that blocking p53 during radiotherapy could minimize acute toxicity while exacerbating late effects including second cancers. Significance: Strategies to prevent or mitigate acute radiation toxicities include pharmacologic inhibition of p53 and other cell death pathways. Our data show that temporarily reducing p53 during irradiation increases late effects including sarcomagenesis.

Isorhamnetin Promotes 53BP1 Recruitment through the Enhancement of ATM Phosphorylation and Protects Mice from Radiation Gastrointestinal Syndrome

Protective Effects of p53 Regulatory Agents Against High-LET Radiation-Induced Injury in Mice

p53 Controls Radiation-Induced Gastrointestinal Syndrome in Mice Independent of Apoptosis

The Protective Effects of Apigenin Against Radiation‐Induced Intestinal Injury

Comparable radiation sensitivity in p53 wild-type and p53 deficient tumor cells associated with different cell death modalities

p53 suppresses MHC class II presentation by intestinal epithelium to protect against radiation-induced gastrointestinal syndrome

The p53 Transactivation Domain 1-Dependent Response to Acute DNA Damage in Endothelial Cells Protects against Radiation-Induced Cardiac Injury

SIRT1 inhibitors mitigate radiation-induced GI syndrome by enhancing intestinal-stem-cell survival

Isorhamnetin Induces Melanoma Cell Apoptosis Via the PI3K/Akt and NF-κB Pathways.

Quantitative Proteomics Analysis of the Effects of Ionizing Radiation in Wild Type and P53k317r Knock-in Mouse Thymocytes

Anti-proliferation effects of isorhamnetin on lung cancer cells in vitro and in vivo

Resveratrol attenuates radiation enteritis through the SIRT1/FOXO3a and PI3K/AKT signaling pathways

Transient HR enhancement by RAD51-stimulatory compound confers protection on intestinal rather than hematopoietic tissue against irradiation in mice

p53 promotes revival stem cells in the regenerating intestine after severe radiation injury

Resveratrol attenuates intestinal injury in irradiated rats via PI3K/Akt/mTOR signaling pathway

Differential Effects of P53 on Bystander Phenotypes Induced by Gamma Ray and High Let Heavy Ion Radiation

Isorhamnetin Enhances the Radiosensitivity of A549 Cells Through Interleukin-13 and the NF-κB Signaling Pathway

Radiation-induced Apoptosis in Developing Mouse Retina Exhibits Dose-Dependent Requirement for ATM Phosphorylation of P53

Temporary Knockdown of p53 During Focal Limb Irradiation Increases the Development of Sarcomas

Isorhamnetin Protects Against Doxorubicin-Induced Cardiotoxicity in Vivo and in Vitro

Resveratrol protects intestinal epithelial cells against radiation-induced damage by promoting autophagy and inhibiting apoptosis through SIRT1 activation